RuSsian RegisTry of Acute CoronaRy SyndromE TreAtMent and Approach in Dual Antiplatelet Therapy (STREAM)

AstraZeneca

Status: Completed

Conditions: Acute Coronary Syndrome

Study type: Observational

Funder types: Industry

Identifiers

NCT02288260

D1843R00242

Details and patient eligibility

About

This NIS is a multi-centre, observational, descriptive, cross-sectional study including all consecutive patients with Acute Coronary Syndrome (ACS) and a single-arm, prospective, longitudinal cohort study which will include patients hospitalized for ACS and who are with ticagrelor on discharge from hospital.

Enrollment: 5,470 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Part A,B: Subjects whose data have been entered in the Russian ACS Registry
• PART A,B: Discharged from hospital after MI with ST-segment elevation (STEMI), MI NST segment elevation (NSTEMI) or Unstable angina. Hospitalized during 24 hours of ACS symptoms onset
• Part B: Patients on ticagrelor at the time of discharge from hospital

Exclusion criteria

• The existence of serious / severe concomitant diseases which can in the short term (i.e. within 6 months) limit the duration of life
• Current participation in a clinical trial with a non-licensed investigational medicinal product

Trial design

5,470 participants in 2 patient groups

Part A

Description:

PATIENTS RECEIVED THE STANDARD MEDICAL CARE AS DETERMINED BY THE TREATING CARDIOLOGIST

Part B

Description:

Patients on ticagrelor at the time of discharge from hospital